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Interestingly, the authors showed that the vast majority
of HSCs (identified in sections as CD150+CD482CD412
cells in some experiments) were closely associated with
these CXCL12-expressing reticular cells. Although most
of the HSCs were located around sinusoids, as ob-
served previously (Kiel et al., 2005), even the HSCs that
were localized to the endosteum or in other locations
were frequently adjacent to CXCL12-expressing reticu-
lar cells. Coupled with the observation that CXCR4-
CXCL12 signaling is required for HSC maintenance in
the bone marrow, these results strongly suggest that
CXCL12-expressing reticular cells contribute to the
formation of vascular niches that maintain many bone-
marrow HSCs. Because the CXCL12-expressing reticu-
lar cells were also adjacent to HSCs at the endosteum,
these results also suggest that the vascular and endos-
teal niches may employ some common mechanisms for
maintaining HSCs.
Although recent reviews of the literature on HSC
niches have focused almost exclusively on the function
of osteoblasts, the study by Sugiyama et al. suggests
that other cells also play critical roles and that factors
that regulate HSC maintenance are not necessarily
produced primarily by osteoblasts. Ultimately, so that
the physiological origins of factors that regulate HSCs
can be elucidated, it will be necessary to conditionally
delete these factors from specific cell types in the bone
marrow. Only then will it be possible to elucidate the
relative contributions of different cell types to the main-
tenance of HSCs. It is likely that many cells contribute
to HSC maintenance, potentially including endothelial
cells, mesenchymal progenitors, megakaryocytes, plate-
lets, and adipocytes, in addition to CXCL12-expressing
reticular cells (Sugiyama et al., 2006), osteoblasts (Calvi
et al., 2003; Zhang et al., 2003), and osteoclasts (Kollet
et al., 2006). Some contributions to the niche may be di-
rect, whereas other contributions may act indirectly
through third-party cells. Some factors may be
delivered by cell-cell interaction, whereas others may
be diffusible and act at a distance. HSCs niches are
likely to be complex assemblies of multiple cell types
that occur around sinusoids, at the endosteum, and in
other locations.
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864Anergic B Cells Caught in the Act
Tolerance of B-lymphocytes to autoantigens is estab-
lished by clonal deletion, receptor editing, and anergy.
In this issue of Immunity, Merrell et al. (2006) have now
identified that T3 ‘‘transitional’’ B cells in the spleen
are not developmental intermediates but rather amajor
population of anergic B cells.
The rearrangement of V, D, and J segments of the IgH
and IgL chain loci and the insertion of P and N nucleo-
tides at the joints during B cell development generate
a seemingly endless variety of diverse B cell receptors
(Melchers et al., 2000). It is likely that newly generatedrepertoires of BCRs on immature B cells display a ran-
dom spectrum of affinities to any given antigen, includ-
ing autoantigens presented to them in the bone marrow.
Most of the newly generated B cells will have either no
or low affinities to a single given autoantigen, and the
frequencies of antigen-binding B cells are expected to
decrease with increasing affinities. In contrast, any
given BCR-expressing immature B cell is expected to
have a similar spectrum of avidities to different anti-
genic structures, including the autoantigens presented
to it in the bone marrow. This variety of autoantigens
should comprise all those antigens expressed on and
in live and dying bone marrow cells, including intercellu-
lar cytoplasmic and nuclear structures. Cell death is
rampant in bone marrow resulting from nonproductively
rearranged or negatively selected B lineage cells. Given
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prise that a large part of all developing B cells have been
found to be autoreactive (Wardemann et al., 2003).
In order to prevent autoimmunity, the newly gener-
ated B cell repertoire is subjected to several selection
processes. Tolerance to autoantigens in the B cell com-
partment is a consequence of clonal deletion (negative
selection) (Nemazee and Burki, 1989), receptor editing
(Nemazee and Weigert, 2000), and anergy induction
(Nossal and Pike, 1980; Goodnow et al., 1988) of the
newly generated cells. Models of Ig-transgenic mice
expressing autoantigen-reactive BCRs with high affini-
ties have suggested that clonal deletion occurs via
high-affinity BCR signaling, leading to accelerated apo-
ptosis of the autoreactive cells, almost exclusively in the
primary lymphoid organ, i.e., centrally in the bone mar-
row. So far it has not been possible to estimate how
many of the 4–8 3 107 cells generated each day from
the earlier precursor B cell pools by proliferation and
differentiation die by clonal deletion, but it is reasonable
to expect that a sizeable part of them to do so.
High-affinity autoreactive B cells might have a chance
to avoid death if they can lower the affinities of their
BCRs through changes of their VH and/or VL domains
of the autoreactive antigen receptors (Nemazee and
Weigert, 2000). Secondary actions on IgH and IgL chain
loci require the continuous expression of rearrangement
machinery, i.e., RAG1 and RAG2. Hence, some of the
precursor and immature B cells in bone marrow express
the RAG enzymes. According to single-cell PCR analy-
ses, approximately two-thirds of all precursor and
immature B cells, i.e., around 3 3 107 cells, have sec-
ondary rearrangements at their kL chain locus and show
an elevated amount of lL chain gene rearrangements as
signs of editing (Melchers et al., 2000). Many of these
actively ‘‘editing’’ B cells, at least half of them, may
never make it out of the bone marrow because cells
with secondary rearrangements are less frequent, i.e.,
constitute only half of all B cells in the immature and
mature compartments of the spleen. Hence, only a pool
of 2 3 107 immature B cells in bone marrow—half
edited, half not edited—appears to be capable of sup-
plying the peripheral B cell pools with cells.
If affinity to an autoantigen is the deciding property of
B cell repertoire selection during development, then it
might be expected that lower-affinity autoreactive B
cells, which are not sufficiently capable of inducing
immediate apoptosis and clonal deletion, could be
arrested in an anergic state. Models of Ig-transgenic
mice expressing lower-avidity BCRs support such
a view. In the anergic state, immature B cells retain
the short life expectancy of other immature and naive
B cells, i.e., a half-life of 2 to 4 days. Hence, they will
quickly disappear from the system, just as naive, mature
B cells that have the same short life expectancy. There-
fore, one difference between anergic and naive B cells is
that anergic B cells are expected to be engaged by the
presence of an autoantigen, whereas naive B cells are
ignored by the autoantigens present in bone marrow.
In fact, it has been shown that continuous presence of
autoantigens is required to keep anergic B cells in
anergy (Gauld et al., 2005). Removal from the autoanti-
genic influence or inhibition of this influence by soluble
autohaptens changes them to naive B cells.Finally the emerging repertoire of B lymphocytes is
also subjected to positive selection—apparently often
to low-affinity autoantigens that are highly crossreactive
with other autoantigens and with bacterial antigens.
This contributes to the establishment of a peripheral B
cell compartment, the BI cell compartment, which is
distinguishable from a B2, conventional B cell compart-
ment by localization, phenotypes, reactiveness, and
antigen-recognition repertoires. Therefore, a spectrum
of emerging diverse repertoires of immature B cells
appear to be selected upon by a spectrum of diverse
autoantigens—making the boundaries between clonal
deletion, receptor editing, anergy, positive selection,
and ignorance somewhat flexible, dependent on sites
of selection and concentrations and crossreactivities
of antigens.
The process of repertoire selection is not fully com-
pleted in the bone marrow of mice but continues in
the organ to which the immature B cells emigrate
first—the spleen. In humans, B cell development in the
bone marrow appears to follow very similar routes and
rules, but because of the limited experimental possibil-
ities, the role of the spleen in the human B cell develop-
ment remains to be studied in greater detail.
With the short half-life of 2–4 days, the pool of 23 107
immature B cells—half edited, half not—supplies the
spleen with 5 3 106 immature B cells per day. These
cells enter a further differentiation pathway via transi-
tional cells, defined by markers and reactivities summa-
rized in Figure 1 (Rolink et al., 1998; Allman et al., 2001).
T1 appears to precede T2, which, in turn, might be
considered to be the immediate precursor of naive ma-
ture B cells in the spleen. From these naive mature B
cells with short half-life, follicular B cells mature to have
a much longer half-life, estimated to be at least in the
order of 15–20 weeks. This maturation to longevity is
induced by B cell activating factor (BAFF, also known
as BIyS) and allows B cells to form the characteristic
B cell-rich regions in the spleen, called follicles. The
total pools of naive and follicular B cells are between
5 and 10 3 107 cells and are slowly replaced by a daily
supply of 23 106 T1 and T2 cells maturing into this pool.
In this issue of Immunity, Merrell et al. (2006) have
now identified the T3 transitional compartment of B
cells in the spleen as a major compartment of anergic
B cells, and they have shown that they are kept in their
anergic state by autoantigens present at the site, i.e., in
spleen. A collection of anergic and nonanergic Ig-trans-
genic mouse strains were used to define the phenotype
of an anergic B cell, so that they could search for such
anergic B cells in normal, nontransgenic B cell reper-
toires. Their analyses indicate that at least one third of
all immature B cells in the spleen are anergic ‘‘T3’’-type
cells. Their antigen-binding repertoires appear to be
shifted toward the recognition of autoantigens. Contin-
uous presence of the splenic autoantigens is required to
retain the anergic state. Biochemical analyses of these
cells show high basal intracellular free calcium concen-
trations, and the cells cannot be stimulated by BCR
occupancy to mobilize calcium, to initiate tyrosine
phosphorylation, to proliferate, or to upregulate typical
B cell activation markers.
A comparison of gene-expression profiles of T3 and
follicular B cells in spleen show very small, if any,
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866Figure 1. Development of B-Lymphocytes in Bone Marrow and Spleen
The number of cells in the various compartments (each cell represents 1.253 106 cells) and their status of kL chain gene rearrangements (purple
cells contain secondary, ‘‘edited’’ kL chain gene loci), as well as estimated daily rates of turnover or transit (within purple box) are shown (see
Melchers et al., 2000). G, germline configuration; V/J, rearranged. From pre-BII to naive B cells, all cells are resting and are short lived, with
half-lives of 2–4 days. Expression of essential markers (+) defining the different developmental stages is shown at the bottom.differences in their transcriptomes. Therefore, the aner-
gic state of a splenic immature B cell, which can be
changed by competition with autohapten of autoantigen
within minutes to the state of a naive cell, is defined by
modifications of posttranscriptional signal-transducing
mechanisms that are connected to calcium concentra-
tions and states of posttranslational changes such as
the phosphorylation of signal-transducing proteins.
The work by Merrell et al. (2006) suggests that T3 cells
are not transitional or developmental intermediates
after T1 and T2, but represent a separate compartment,
which the authors have suggested renaming ‘‘An1.’’ The
identification of An1 (T3) cells as anergic splenic B cells
immediately poses the question whether a similar com-
partment exists in the bone marrow. It is also reason-
able to expect that not all anergic cells have the same
phenotype, given that a variety of different autoantigens
with different affinities are acting on a highly diverse
repertoire of antigen-recognizing B cells. If different
affinities of BCRs, exposed to different concentrations
of autoantigens, possibly at different sites of anergy in-
duction, influence this phenotype and the appearance
of such cells in either bone marrow or spleen, then it be-
comes understandable why different Ig-transgenic,
autoantigen-recognizing B cells show differences in
their anergic phenotype. It remains astounding that less
than 10% of the newly generated immature B cells in
bone marrow make it into the mature, follicular B cell
pool as nonautoreactive cells (Figure 1). Although clonaldeletion by accelerated apoptosis provides a reper-
toire-purging mechanism that allows a stable establish-
ment of tolerance, anergic B cells remain a danger be-
cause they are autoantigen dependent and easily
relieved from anergy by autoantigenic hapten inhibition.
It is a danger that is only kept in check by the short half-
life of an anergic B cell in the immune system.
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Rulers over Randomness:
Stroma Cells Guide Lymphocyte
Migration in Lymph Nodes
How is the amoeboid movement of lymphocytes in
secondary lymphoid organs orchestrated? In this
issue of Immunity, Baje´noff et al. (2006) demonstrate
that stromal cell networks serve as guidance struc-
tures that direct and limit themigration of B and T cells
in lymph nodes.
Secondary lymphoid organs (SLOs), including lymph
nodes (LN), are hubs of leukocyte trafficking and pro-
vide structural platforms for information transfer be-
tween innate and adaptive immune cells (von Andrian
and Mempel, 2003). SLOs have evolved to optimize
the likelihood that rare lymphocytes with unique anti-
genic specificity encounter their cognate antigen in
the appropriate immunogenic or tolerogenic context.
Critical to the success of this system are search strate-
gies that maximize the exposure of each individual
lymphocyte to the largest possible number of antigen-
presenting cells (APCs). To this end, naive lymphocytes
must incessantly recirculate between blood and SLOs,
spending typically less than a day in each organ and
migrating actively within the interstitial space to query
vast numbers of APCs along their path.
Recent observations with confocal and multiphoton
intravital microscopy of fluorescently tagged immune
cells in their natural habitat have reshaped our under-
standing of how adaptive immune responses are initi-
ated and regulated in LNs. Initial studies had noted that
T and B cell migration was not only more dynamic than
anticipated but also apparently random in direction.
The observed migratory patterns seemed best de-
scribed by a refined version of the random-walk model,
which is classically used to describe the diffusion of
particles (Miller et al., 2002). There are, however, several
caveats that must be kept in mind when fluorescence-
based intravital imaging studies are performed in SLOs:
the relatively small sample volume that can be imaged
within the organ; the limited duration of continuous re-
cordings (typically one hour or less); the small fraction
of any particular cell population that can be visualized;
and the inability to simultaneously detect and discrimi-
nate between the many diverse constituents of the LNNossal, G.J., and Pike, B.L. (1980). Proc. Natl. Acad. Sci. USA 77,
1602–1606.
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microenvironment (e.g., nonfluorescent immune cells,
blood vessels, stromal cells, extracellular matrix, etc.).
Despite these uncertainties, motility data have been
interpreted as if lymphocytes were migrating in a ho-
mogenous matrix (composed of invisible lymphocytes)
without physical obstacles or a stationary adhesion
substrate. The migrating cells’ behavior was likened to
that of autonomous agents that follow an intrinsic
search algorithm (Miller et al., 2003). Characteristic as-
pects of this behavior were minute-long phases of mi-
gration along a fairly straight path interrupted by short
migratory pauses during which cells were believed to
reorient their locomotion machinery. Calculations have
shown that the high motility of randomly migrating T
cells, combined with the ability of dendritic cells (DCs)
to maximize the volume within which they display anti-
gens by sweeping their expansive dendrites in the sur-
rounding space, allows for a high scanning efficiency.
Published estimates range from 500 to as many as
5000 T cells that may contact individual DCs per hour
(Breart and Bousso, 2006).
Although the erratic movement of interstitial lympho-
cytes negates a simple role for diffusible chemoattrac-
tants exerting long-distance directional control over
lymphocyte migration, several observations demand
the existence of hidden rules that restrict migratory ran-
domness. A striking case in point is the strict separation
of B follicles and the T cell area. B and T cells migrate
vigorously in their respective domains, but rarely tres-
pass into each other’s territory. Experiments in knockout
mice have established long ago that chemokines are
essential for this compartmentalization, and recent
imaging studies in LNs show that chemokines control
T and B cell migration also at the single-cell level, at least
under certain conditions. For example, when intrafolli-
cular B cells encounter antigen, they upregulate the
chemokine receptor CCR7, thus sensitizing themselves
to the abundant CCR7 ligands in the T cell area, which
attract them to the follicle border (Okada et al., 2005).
Similarly, activation of CD4+ T cells induces CXCR5,
which allows T cells to access the B cell follicle to provide
B cell help. Moreover, naive CD8+ T cells rapidly upregu-
late CCR5 when they enter LNs that drain a vaccination
site. Antigen-presenting DCs are prompted by activated
CD4+ T cells to secrete CCR5 ligands. This increases the
contact frequency between CCR5+ CD8+ T cells and the
‘‘helped’’ DCs (Castellino et al., 2006).
In vitro, chemokines diffusing in solution or across gels
or membranes establish concentration gradients that
